Effects of inhibition of PDE4 and TNF‐α on local and remote injuries following ischaemia and reperfusion injury
- 1 November 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 134 (5), 985-994
- https://doi.org/10.1038/sj.bjp.0704336
Abstract
1. The effects of phosphodiesterase (PDE)4 and TNF-alpha inhibition were assessed on the local and remote injuries following intestinal ischaemia and reperfusion (I/R) injury in rats. 2. The PDE4 inhibitor rolipram dose-dependently (1 - 10 mg kg(-1)) suppressed the local (intestine) and remote (lung) increases in vascular permeability and neutrophil recruitment following mild I/R injury. SB207499 (ariflo), a structurally-distinct PDE4 inhibitor, also suppressed the injuries following mild I/R injury. 3. In a severe model of I/R injury, treatment with rolipram (10 mg kg(-1)) partially reversed the local and remote increases in vascular permeability, neutrophil recruitment, intestinal haemorrhage and intestinal LTB(4) concentrations. The anti-TNF-alpha anti-serum was more effective than rolipram at inhibiting local and remote injuries and prevented the lethality associated with severe I/R. 4. Rolipram and anti-TNF-alpha prevented the increase in the concentrations of TNF-alpha in the lung and intestine, but rolipram only partially inhibited the elevation of this cytokine in serum. Rolipram had little effect on the increases of IL-1 beta concentrations in lung and serum, whereas treatment with anti-TNF-alpha markedly increased the concentration of this cytokine. Concentrations of IL-10 rose significantly in the lung and serum and these increases were blocked by rolipram or anti-TNF-alpha. 5. The capacity of PDE4 inhibitors to block the recruitment of neutrophils into tissues, the production of LTB(4) and of the pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6 appear to underlie their anti-inflammatory effects in our model of I/R injury. Overall, PDE4 inhibition was less effective than inhibition of TNF-alpha for protection against I/R injury.Keywords
This publication has 42 references indexed in Scilit:
- ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL-10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGMShock, 2000
- Differential inhibitory mechanism of cyclic AMP on TNF‐α and IL‐12 synthesis by macrophages exposed to microbial stimuliBritish Journal of Pharmacology, 1999
- Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/ReperfusionCirculation, 1998
- Splanchnic origin of cytokines in a porcine model of mesenteric ischemia-reperfusionSurgery, 1998
- Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends in Pharmacological Sciences, 1997
- Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends in Pharmacological Sciences, 1997
- PROTECTION BY PENTOXIFYLLINE AGAINST NORMOTHERMIC LIVER ISCHEMIA/REPERFUSION IN RATSTransplantation, 1995
- Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.The Journal of Experimental Medicine, 1994
- Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitorsInflammation Research, 1993
- Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injuryThe Annals of Thoracic Surgery, 1991